Biogen (BIIB) Operating Margin (2016 - 2025)
Historic Operating Margin for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to 24.19%.
- Biogen's Operating Margin fell 123000.0% to 24.19% in Q4 2025 from the same period last year, while for Dec 2025 it was 8.57%, marking a year-over-year decrease of 43900.0%. This contributed to the annual value of 8.57% for FY2025, which is 43900.0% down from last year.
- Biogen's Operating Margin amounted to 24.19% in Q4 2025, which was down 123000.0% from 4.62% recorded in Q3 2025.
- Over the past 5 years, Biogen's Operating Margin peaked at 36.15% during Q1 2021, and registered a low of 31.65% during Q3 2023.
- In the last 5 years, Biogen's Operating Margin had a median value of 3.0% in 2023 and averaged 4.62%.
- In the last 5 years, Biogen's Operating Margin soared by 330700bps in 2021 and then crashed by -675900bps in 2023.
- Quarter analysis of 5 years shows Biogen's Operating Margin stood at 21.48% in 2021, then crashed by -94bps to 1.29% in 2022, then tumbled by -1159bps to 13.69% in 2023, then increased by 13bps to 11.9% in 2024, then tumbled by -103bps to 24.19% in 2025.
- Its Operating Margin stands at 24.19% for Q4 2025, versus 4.62% for Q3 2025 and 5.25% for Q2 2025.